Industries de la santé
16 Janvier 2014
A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level.... |Plus d'articles...
- Estrogen Protects Women with NASH from Severe Liver Fibrosis
- Measuring Segments of Genetic Material May Help Predict and Monitor Recurrence after Thyroid Cancer Surgery
- InterSystems parmi les « Visionnaires » du Magic Quadrant de Gartner et parmi les « Leaders » au travers de ses partenaires
- The benefits of bacteria for gut health